Cholesteryl ester transfer protein polymorphism D442G associated with a potential decreased risk for Alzheimer's disease as a modifier for APOE ε4 in Chinese

Brain Research

Volumn 1187, Issue 1, 2008, Pages 52-57

  Chen, Da Wei ^a,b   Yang, Jing Fang ^a,b   Tang, Zhe ^a,b   Dong, Xiu Min ^a,b   Feng, Xiu Li ^c   Yu, Shun ^a,b   Chan, Piu ^a,b,c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

Author keywords

Alzheimer's disease; Apolipoprotein E; Cholesterol ester transfer protein; High density lipoprotein; Single nucleotide polymorphism

Indexed keywords

APOLIPOPROTEIN E4; CHOLESTEROL ESTER TRANSFER PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; ASIAN CONTINENTAL ANCESTRY GROUP; CHOLESTEROL ESTER TRANSFER PROTEINS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HETEROZYGOTE; HUMANS; LIPOPROTEINS, HDL; MALE; POLYMORPHISM, GENETIC; SEX DISTRIBUTION;

EID: 36549023326     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.10.054     Document Type: Article

References (25)

1. Albers J.J., Tollefson J.H., Wolfbauer G., and Albright Jr. R.E. Cholesteryl ester transfer protein in human brain. Int. J. Clin. Lab. Res. 21 (1992) 264-266
2. Arai H., Yamamoto A., Matsuzawa Y., Saito Y., Yamada N., Oikawa S., Mabuchi H., Teramoto T., Sasaki J., Nakaya N., Itakura H., Ishikawa Y., Ouchi Y., Horibe H., Egashira T., Hattori H., Shirahashi N., and Kita T. Polymorphisms in four genes related to triglyceride and HDL-cholesterol levels in the general Japanese population in 2000. J. Atheroscler. Thromb. 12 (2005) 240-250
3. Arashiro R., Katsuren K., Maung K.K., Fukuyama S., and Ohta T. Effect of a common mutation (D442G) of the cholesteryl ester transfer protein gene on lipids and lipoproteins in children. Pediatr. Res. 50 (2001) 455-459
4. Bessenyei B., Marka M., Urban L., Zeher M., and Semsei I. Single nucleotide polymorphisms: aging and diseases. Biogerontology 5 (2004) 291-303
5. Boekholdt S.M., and Thompson J.F. Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease. J. Lipid Res. 44 (2003) 1080-1093
6. Bruce C., Sharp D.S., and Tall A.R. Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia. J. Lipid Res. 39 (1998) 1071-1078
7. Chong P.H., Kezele R., and Franklin C. High-density lipoprotein cholesterol and the role of statins. Circ. J. 66 (2002) 1037-1044
8. Fagan A.M., Younkin L.H., Morris J.C., Fryer J.D., Cole T.G., Younkin S.G., and Holtzman DM. Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype. Ann. Neurol. 48 (2000) 201-210
9. Fidani L., Goulas A., Crook R., Petersen R.C., Tangalos E., Kotsis A., and Hardy J. An association study of the cholesteryl ester transfer protein TaqI B polymorphism with late onset Alzheimer's disease. Neurosci. Lett. 357 (2004) 152-154
10. Gustincich S., Manfioletti G., Del-Sal G., Schneider C., and Carninci P. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques 11 (1991) 298-300
11. Hixson J.E., and Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31 (1990) 545-548
12. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
13. Merched A., Xia Y., Visvikis S., Serot J.M., and Siest G. Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease. Neurobiol. Aging 21 (2000) 27-30
14. Michikawa M. Neurodegenerative disorders and cholesterol. Curr. Alzheimer Res. 4 (2004) 271-275
15. Mulder M., Ravid R., Swaab D.F., de Kloet E.R., Haasdijk E.D., Julk J., van der Boom J.J., and Havekes L.M. Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4. Alzheimer Dis. Assoc. Disord. 12 (1998) 198-203
16. Rodriguez E., Mateo I., Infante J., Llorca J., Berciano J., and Combarros O. Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele. J. Neurol. 253 (2006) 181-185
17. Sakai N., Yamashita S., Hirano K., Menju M., Arai T., Kobayashi K., shigami M., Yoshida Y., Hoshino T., and Nakajima N. Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects. Atherosclerosis 114 (1995) 139-145
18. Schmidt R.F., Nordestgaard B.G., Larsen B.A., Schnohr P., and Hansen A.T. Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype. J. Lipid Res. 41 (2000) 1812-1822
19. Tang Z., and Xiang M.J. Outcome of three year follow-up for elderly people with dementia in urban and rural areas of Beijing. Chin. J. Geriatr. 22 (2003) 305-307
20. Van der Steeg W.A., Kuivenhoven J.A., Klerkx A.H., Boekholdt S.M., Hovingh G.K., and Kastelein J.J. Role of CETP inhibitors in the treatment of dyslipidemia. Curr. Opin. Lipidol. 15 (2004) 631-636
21. Yamada T., Kawata M., Arai H., Fukasawa M., Inoue K., and Sato T. Astroglial localization of cholesteryl ester transfer protein in normal and Alzheimer's disease brain tissues. Acta Neuropathol. (Berl) 90 (1995) 633-636
22. Yamashita S., Hirano K., Sakai N., and Matsuzawa Y. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein. Biochim. Biophys. Acta 1529 (2000) 257-275
23. Zhang K.Q., Zhang S.Z., Zhang L., Huang D.J., Liao L.C., and Huo Y.P. A novel missense mutation (L296Q) in cholesteryl ester transfer protein gene related to coronary heart disease. Acta Biochim. Biophysica. Sinica 36 (2004) 33-36
24. Zhao F.G., Wang Y.H., Yang J.F., Ma Q.L., Tang Z., Dong X.M., and Chan P. Association between acyl-coenzyme A: cholesterol acyltransferase gene and risk for Alzheimer's disease in Chinese. Neurosci. Lett. 388 (2005) 17-20
25. Zhu H., Gopalraj R.K., Kelly J.F., Bennett D.A., and Estus S. Lack of genetic association of cholesteryl ester transfer protein polymorphisms with late onset Alzheimer's disease. Neurosci. Lett. 381 (2005) 36-41